Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Ceylon Med J ; 67(1): 17-19, 2022 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-37608000

RESUMEN

Abstract: Bone marrow failure (BMF) in children can be idiopathic (70-80%) or inherited. Haematopoietic stem cell transplantation (HSCT) is the only cure for both causes. Allogeneic HSCT requires a suitable donor. Many children will not have a HLA matched sibling or unrelated donor. A haploidentical donor is available for all children as eaazch parent will have at minimum a 50% HLA match. This report of a 7-year old girl with BMF treated with a haplo-HSCT, the first in Sri Lanka, highlights the importance of developing a haploidentical HSCT programme as a potential cure for a disease with a dismal outcome.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Niño , Femenino , Humanos , Sri Lanka , Trastornos de Fallo de la Médula Ósea/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA